DNAPrint Genomics Inc DNAG
$0.00
Last Updated: Aug 06, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
DNAPrint Genomics Inc. Stock Analysis DNAG
United States Health Care Nano Cap DNAPrint Genomics, Inc. engages in the research and development of genomics-based products and services for biomedical and forensics. The company is headquartered in Swampscott, Massachusetts and currently employs 24 full-time employees. The company went IPO on 2001-02-23. As of March 15, 2007, the Company’s pharmacogenomics products were still in development. The firm generates revenues in its consumer, forensic and genotyping services, but these services have not resulted in the generation of significant revenues. During the year ended December 31, 2006, the Company’s revenues were from the sales of its ancestry product, AncestryByDNA and genotyping services. The firm provides services that range from sequencing and genotyping to the entire process of single nucleotide polymorphisms (SNP) discovery to large industrial customers. Contract genotyping is the process of reading a genetic sequence and identifying differences in the sequence letters. This information helps researchers understand how human differences are expressed at the gene level.
DNAPrint Genomics Inc (DNAG) Chart
Financial Metrics & Statements of DNAPrint Genomics Inc (DNAG)
FAQ's for DNAPrint Genomics Inc (DNAG)
- As of August 2026, DNAPrint Genomics Inc DNAG is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes DNAPrint Genomics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in DNAPrint Genomics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of DNAPrint Genomics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of DNAPrint Genomics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of DNAPrint Genomics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for DNAPrint Genomics Inc (DNAG)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
